Related Experiment Video
Updated: Sep 30, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Effect of combination antiretroviral therapy on cytomegalovirus retinitis
1Banker's Retina Clinic and Laser Centre, 5 Subhash Society, Behind Ishvar Bhuvan, Ahmedabad 380 009, India. banker@egujarat.net
Purpose:
To study the various changes in the course of cytomegalovirus (CMV) retinitis following combination antiretroviral treatment.
Methods:
Combination antiretroviral treatment was given to 12 patients with active CMV retinitis following which all anti-CMV medications were discontinued once the CD4 cell counts were > 100/mm3 for 3 months.
Results:
The median CD4 cell count increased from 36.5/mm3 (range, 3-74/mm3) at baseline to 175.5/mm3 (range, 97-410/mm3) at 3 months. No patient had reactivation of CMV retinitis or developed extraocular CMV infection during median follow-up of 16.7 months. In one patient with peripheral active CMV retinitis, the retinitis resolved completely and remained so throughout the follow-up period without specific anti-CMV treatment. Five (41.7%) patients had immune recovery vitritis.
Conclusion:
Patients receiving combination antiretroviral treatment following treatment for CMV retinitis have better control of CMV retinitis but immune recovery vitritis is a common sequelae. Reactivation of CMV retinitis is common in patients who discontinue combination antiretroviral treatment.
Related Concept Videos
Cytomegalovirus Disease
Retrovirus Life Cycles
Cryptococcal Meningitis
Antiviral Nucleoside Inhibitors
Diabetic Retinopathy
Inhibitors of Viral Protein Synthesis